Top Markets
#1 Black Phoenix Black Phoenix +2,491.82%
#2 Nesa Nesa +752.82%
#3 Ontology Gas Ontology Gas +149.16%
#4 ADO Protocol ADO Protocol +104.23%
#5 Cortex Cortex +95.96%
#6 Kinesis Silver Kinesis Silver +54.68%
#7 Magma Finance Magma Finance +36.61%
#8 Cash Cat Cash Cat +33.74%
#9 OpenEden OpenEden +31.29%
#10 Non-Playable Coin Non-Playable Coin +31.16%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
UniQure N.V. UniQure N.V.

UniQure N.V.

QURE
Rang in aandelen #4587
uniQure N.V. develops treatments for patients suffering from rare and other... uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in phase I/II clinical study for the treatment of Huntington’s disease. The company also develops AMT-260, which is in phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Aandeelprijs
$50.67
Marktkapitalisatie
$3.51B
Verandering (1 dag)
-0.75%
Verandering (1 jaar)
220.87%
Land
NL
Handel UniQure N.V. (QURE)

Categorie

Healthcare
Dividendrendementgeschiedenis voor UniQure N.V. (QURE)
Het dividendrendement (TTM) van UniQure N.V. (aandelsymbool: QURE) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van UniQure N.V. (QURE) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH